fura-2 has been researched along with fendiline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, R; Cheng, J; Chou, K; Chung Lee, K; Jan, C; Lo, Y; Tang, K; Tseng, L; Wang, J | 1 |
| Huang, JK; Jan, CR; Yu, CC | 1 |
| Chang, HT; Cheng, JS; Chou, KJ; Jan, CR; Lee, KC; Lo, YK; Tang, KY; Wang, JL | 1 |
| Chen, I; Cheng, J; Chou, C; Huang, C; Jan, C; Liu, S; Tsai, J; Tseng, P | 1 |
4 other study(ies) available for fura-2 and fendiline
| Article | Year |
|---|---|
The anti-anginal drug fendiline increases intracellular Ca(2+) levels in MG63 human osteosarcoma cells.
Topics: Calcium; Calcium Channel Blockers; Carcinogens; Chelating Agents; Fendiline; Fura-2; Humans; Osteosarcoma; Thapsigargin; Tumor Cells, Cultured; Verapamil | 2001 |
Dual effect of the antianginal drug fendiline on bladder female transitional carcinoma cells: mobilization of intracellular CA2+ and induction of cell death.
Topics: Anti-Arrhythmia Agents; Calcium; Carcinoma, Transitional Cell; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Female; Fendiline; Fluorescent Dyes; Fura-2; Humans; Inositol 1,4,5-Trisphosphate; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2001 |
Fendiline-Induced Ca2+ movement in A10 smooth muscle cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Fendiline; Fluorescent Dyes; Fura-2; Lanthanum; Muscle, Smooth, Vascular; Nifedipine; Thapsigargin; Vasodilator Agents; Verapamil | 2001 |
Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Estrenes; Fendiline; Fluorescent Dyes; Fura-2; Humans; Mouth Neoplasms; Nifedipine; Phosphodiesterase Inhibitors; Pyrrolidinones; Tetrazolium Salts; Thapsigargin | 2009 |